CARDIOVIT AT-102 G2
High performance in busy environments
- Caregivers can perform an EKG in just 3 minutes, from preparation to PDF, thanks to our unique 1-2-3 step process and 3D model features.
- 12-lead Resting and Rhythm ECG with Interpretation.
- 350 Memory (Resting ECG), 100 Memory (Rhythm ECG).
- 8 hours Battery Life.
- Built-in full-size Thermal Printer ( 8.5 in. x 11 inch) printout.
- Longest Resting Rhythm in the market up to 10 min.
- The CARDIOVIT AT-102 G2 offers the highest acquisition quality with a 32,000 Hz sampling rate for accurate atrial fibrillation detection.
- The high bandwidth (250 Hz) allows for the highest quality EKG recordings from neonates and pediatric patients.
- The AT-102 G2 offers simple connectivity that adapts perfectly to your existing network, providing various options to acquire, print, save, and transmit ECG data.
- Seamless bidirectional connectivity supports a paperless workflow and saves time.
- Its bidirectional communication capability through Ethernet and Wi-Fi enables the fastest automatic transmission to PDF exports or EMR systems, improving workflow.
- It can connect to PACS systems using DICOM and HL7 for Worklist and Patient Information Query.
Emergency Department, EMS, Urgent Care, Field Hospitals, Clinics, Primary Care, Internal Medicine, Family Practice, Cardiologist, Pediatric Cardiologist, Research Lab, Home Care, Occupational Health, Telemedicine, and Travel Nurse or Doctor.
93000 EKG Routine 12-Lead interpretation and report.
93005 EKG Tracing Only.
93010 EKG Interpretation and Report Only.
* CPT codes and reimbursements are provided as an example only and constitute no promise by SCHILLER or its subsidiaries regarding coverage or payment.
Connect with us today
Contact your SCHILLER representative today if you are interested in learning more or scheduling a demo.
SCHILLER reserves the right to make changes in design, specifications and features shown, or discontinue the product described at any time without notice or obligation. Images may be representative. Device availability in your market is subject to regulatory approval.
